Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease. Pediatr Dermatol 2021 Sep;38(5):1020-1031

Date

07/18/2021

Pubmed ID

34272748

DOI

10.1111/pde.14688

Scopus ID

2-s2.0-85110352628   1 Citation

Abstract

Pediatric morphea is an inflammatory, fibrosing dermatologic disorder. Although morphea may be localized to the skin and subcutaneous tissues, differentiating it from systemic sclerosis, there is increasing evidence that morphea is a manifestation of a systemic inflammatory process, with the potential to involve many organ systems. Given the potential risk for irreversible sequelae, pediatric morphea should be treated early and aggressively. Long-term disease monitoring is essential.

Author List

Sink JR, Chiu YE

Author

Yvonne E. Chiu MD Vice Chair, Professor in the Dermatology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Child
Disease Progression
Humans
Scleroderma, Localized
Scleroderma, Systemic
Skin